Evidence map›Paper›PMID 41296239›Full record

ArticleDiscover oncology2025

Deep learning model outperforms traditional models in clinical data-based prognostic prediction for adult-type diffuse glioma.

Xiaopeng Li, Chongshun Zhao, Yanpeng Xia, Ya Zhang, Qian Zhang, Mengdan Miao, Zhijiang Xie, Hongjing Yan, Tao Zhou, Shuanli Xin

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaopeng Li *Department of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China.
Chongshun Zhao *Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
Yanpeng XiaDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China.
Ya ZhangDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China.
Qian ZhangDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China.
Mengdan MiaoDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China.
Zhijiang XieDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China.
Hongjing YanDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China.
Tao ZhouDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China. Zhoutaoyan2004@163.com.
Shuanli XinDepartment of Neurosurgery, Handan First Hospital, Handan, 056002, Hebei, People's Republic of China. hdxinshuanli@126.com.

Funding

2025 Hebei Province Yanzhao Huangjintai Key Talent Project B20250020022026 Hebei Provincial Medical Science Research Project 20261255Hebei Provincial Health Commission Medical Scientific Research Project Plan 20240383
6 · The paper itself

Abstract

objectiveThis study aims to systematically compare traditional statistical methods and machine learning approaches for survival prediction in adult-type diffuse glioma (ADG), evaluating their performance, interpretability, and clinical applicability.

methodsUsing two public datasets and one private retrospective cohort, four models (Cox Proportional Hazards, Random Survival Forest, Neural Multi Task Logistic Regression, and DeepSurv) were developed and validated. Missing values were handled in three different ways and subjected to sensitivity analysis.

resultsIn both the internal test cohorts and two external validation cohorts, the neural network-based deep learning model outperformed the random survival forest and Cox proportional hazards model, with the DeepSurv model demonstrating the most robust performance. Key prognostic factors included age, molecular pathology, chemotherapy, extent of resection, extent of disease, and radiotherapy. Sensitivity analysis confirmed model stability. The model has been packaged and made publicly available.

conclusionFor retrospective real-world ADG patient data with high heterogeneity and partial missingness, the DeepSurv model demonstrates superior survival prediction performance and stability compared to conventional approaches.

Indexed as

Deep learningGliomaMachine learningPrognostic modelingSurvival analysis

Identifiers

PMID41296239
PMCPMC12748360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.